M&T Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.48M Sell
4,408
-1,574
-26% -$1.01M 0.01% 547
2025
Q4
$4.05M Buy
5,982
+2,465
+70% +$1.68M 0.01% 456
2025
Q3
$2.25M Sell
3,517
-1,047
-23% -$636K 0.01% 563
2025
Q2
$2.45M Buy
4,564
+168
+4% +$80.3K 0.01% 564
2025
Q1
$1.85M Sell
4,396
-884
-17% -$384K 0.01% 636
2024
Q4
$2.18M Sell
5,280
-413
-7% -$181K 0.01% 643
2024
Q3
$2.88M Buy
5,693
+92
+2% +$44.7K 0.01% 563
2024
Q2
$2.73M Sell
5,601
-152
-3% -$76.3K 0.01% 553
2024
Q1
$3.11M Sell
5,753
-392
-6% -$214K 0.01% 516
2023
Q4
$3.41M Sell
6,145
-25
-0.4% -$11.7K 0.01% 487
2023
Q3
$2.7M Sell
6,170
-1,480
-19% -$738K 0.01% 522
2023
Q2
$3.84M Sell
7,650
-193
-2% -$92.5K 0.01% 467
2023
Q1
$3.92M Sell
7,843
-258
-3% -$123K 0.02% 463
2022
Q4
$3.31M Buy
8,101
+118
+1% +$45.8K 0.01% 487
2022
Q3
$2.6M Sell
7,983
-3,817
-32% -$1.4M 0.01% 521
2022
Q2
$1.24M Buy
11,800
+8,699
+281% +$3.55M 0.01% 700
2022
Q1
$1.7M Sell
3,101
-649
-17% -$341K 0.01% 613
2021
Q4
$2.47M Sell
3,750
-67
-2% -$42.1K 0.01% 520
2021
Q3
$2.37M Sell
3,817
-853
-18% -$573K 0.01% 518
2021
Q2
$2.95M Sell
4,670
-613
-12% -$338K 0.01% 485
2021
Q1
$2.58M Sell
5,283
-4,285
-45% -$2.15M 0.01% 501
2020
Q4
$4.78M Sell
9,568
-285
-3% -$128K 0.02% 376
2020
Q3
$3.87M Sell
9,853
-789
-7% -$292K 0.02% 389
2020
Q2
$3.51M Sell
10,642
-1,171
-10% -$339K 0.02% 393
2020
Q1
$2.86M Sell
11,813
-809
-6% -$211K 0.02% 435
2019
Q4
$3.3M Sell
12,622
-3,470
-22% -$914K 0.02% 346
2019
Q3
$4.38M Sell
16,092
-784
-5% -$218K 0.02% 344
2019
Q2
$4.65M Sell
16,876
-239
-1% -$58.9K 0.02% 346
2019
Q1
$3.83M Sell
17,115
-169
-1% -$34.9K 0.02% 368
2018
Q4
$3.21M Sell
17,284
-55
-0.3% -$11.3K 0.02% 383
2018
Q3
$4.33M Buy
17,339
+6,743
+64% +$1.64M 0.02% 372
2018
Q2
$2.31M Buy
10,596
+45
+0.4% +$9.27K 0.01% 511
2018
Q1
$2.02M Sell
10,551
-152
-1% -$28.1K 0.01% 536
2017
Q4
$1.68M Sell
10,703
-33
-0.3% -$5.19K 0.01% 594
2017
Q3
$1.67M Sell
10,736
-1,393
-11% -$220K 0.01% 589
2017
Q2
$1.96M Sell
12,129
-363
-3% -$59K 0.01% 544
2017
Q1
$1.93M Sell
12,492
-1,536
-11% -$212K 0.01% 541
2016
Q4
$1.65M Sell
14,028
-751
-5% -$85.7K 0.01% 615
2016
Q3
$1.67M Buy
14,779
+2,928
+25% +$309K 0.01% 604
2016
Q2
$1.1M Sell
11,851
-2,276
-16% -$195K 0.01% 742
2016
Q1
$1.11M Sell
14,127
-18,653
-57% -$1.34M 0.01% 745
2015
Q4
$2.39M Sell
32,780
-10,668
-25% -$761K 0.02% 509
2015
Q3
$3.23M Buy
43,448
+4,431
+11% +$317K 0.02% 424
2015
Q2
$2.5M Buy
39,017
+5,721
+17% +$396K 0.02% 561
2015
Q1
$2.57M Buy
33,296
+19,426
+140% +$1.51M 0.02% 547
2014
Q4
$1.03M Buy
13,870
+970
+8% +$68K 0.01% 849
2014
Q3
$760K Buy
+12,900
New +$816K ﹤0.01% 1020

Other funds holding IDXX

M&T Bank's IDXX Position: Q1 2026 in Review

M&T Bank reduced its Idexx Laboratories (IDXX) stake by 26% in Q1 2026, selling an estimated $1.01M and leaving 4,408 shares worth $2.48M. The position accounts for 0.01% of the portfolio, ranked #547.

M&T Bank first reported a position in IDXX in Q3 2014 and has held it in 47 quarters since. The position peaked at $4.78M in Q4 2020. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • M&T Bank held 4,408 shares of Idexx Laboratories worth $2.48M as of Q1 2026.
  • M&T Bank sold 1,574 Idexx Laboratories shares in Q1 2026, an estimated $1.01M.
  • Idexx Laboratories made up 0.01% of M&T Bank's portfolio in Q1 2026, its #547 holding.
  • M&T Bank first reported a position in Idexx Laboratories in Q3 2014 and has held it in 47 quarters since.
  • M&T Bank's Idexx Laboratories position peaked at $4.78M in Q4 2020.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.